- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04272840
The Impact of Glycemic Index Education on Lowering Dietary GI in Gestational Diabetes Mellitus
March 29, 2022 updated by: Shannan Grant, IWK Health Centre
Adapting a National Glycemic Index Education Platform for Nova Scotian Patients and Clinicians Treating Gestational Diabetes Mellitus Using Distance Education Strategies.
Gestational Diabetes Mellitus (GDM) incidence is increasing worldwide, and within Canada, the Atlantic provinces statistically have been found to have highest prevalence of diabetes.
Increasing evidence supports the benefit of following a low glycaemic index (GI) diet in GDM and the Canadian Diabetes Guidelines recommends replacing high GI foods for low GI foods.
Despite recommendation to adapt a low GI diet in GDM, there are limitations and barriers recognized to GI utility largely focused on knowledge translation.
There is sufficient research to support a low GI diet in benefiting outcomes of GDM, therefore the GI in GDM Online trial will investigate the feasibility and effectiveness of a distance low GI education intervention, adapted from Diabetes Canada's GI materials, on producing a difference in average dietary GI between a group with the intervention and standard care.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The incidence of Gestational Diabetes Mellitus (GDM) has been progressively increasing worldwide, with a global prevalence of gestational hyperglycaemia estimated at 16.9%.
In Canada, Atlantic provinces have been recorded with the highest prevalence of diabetes at 6%.
The Diabetes Canada Practice Guidelines recommends the low glycemic index (GI) diet to type 1 and 2 diabetes mellitus and has recently updated its guidelines to include a recommendation for GDM.
This said, barriers to GI knowledge translation have been identified.
This study uses a prospective parallel randomized control trial design.
Procedures and materials have been adapted from NCT01589757.
The Kirkpatrick Model (Reaction, Learning, Behaviour, and Results) informed intervention development and evaluation strategies.
The purpose of this study is to evaluate whether a distance low GI education intervention, adapted from Diabetes Canada's GI education materials, will significantly yield a lower average GI (primary outcome) in participants than traditional standard care medical nutrition therapy for Gestational Diabetes Mellitus.
We hypothesize that participants who receive the low GI intervention will have a lower dietary GI than those who received usual IWK standard care for GDM.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Shannan Grant, PhD, PDt
- Phone Number: 902-457-5400
- Email: shannan.grant2@msvu.ca
Study Contact Backup
- Name: Julianne Leblanc, BSc
- Phone Number: (902)470-6532
- Email: julianne.leblanc@iwk.nshealth.ca
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3K 6R8
- Recruiting
- IWK Health Centre
-
Contact:
- Shannan Grant, PDt,MSc,PhD
- Phone Number: (902)457-5400
- Email: shannan.grant@iwk.nshealth.ca
-
Contact:
- Julianne LeBlanc, MSc Student
- Phone Number: (902)470-6532
- Email: julianne.leblanc@iwk.nshealth.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Of or over 18 years of age
- Diagnosed with GDM according to Diabetes Canada
- At or over than 20 weeks gestation
- At or less than 32 weeks gestation
- Being followed at IWK Health Centre
- Willing and able to give informed consent
- Willing and able to complete study protocol
- Currently living in Nova Scotia
Exclusion Criteria; women who:
- have been diagnosed with acute or chronic illness, other than GDM and PCOS, that may impact carbohydrate digestion metabolism.
- are currently taking a medication (other than insulin) that may affect carbohydrate metabolism.
- have multi-fetal pregnancy in current pregnancy.
- have insurmountable language barriers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Standard Care
Participants will attend a 30-45 min workshop.
Trainees will review Diabetes Canada Clinical Practice Guidelines Job Aids (Just the Basics, the Handy Portion Guide, and Basic Carbohydrate Counting) and teach data provision skills (how to complete a three day diet record).
|
|
EXPERIMENTAL: Low Glycemic Index
Standard care + Glycemic Index.
Participants will attend a 30-45 min workshop.
Trainees will review Diabetes Canada Clinical Practice Guidelines Job Aids (Just the Basics, the Handy Portion Guide, and Basic Carbohydrate Counting) and teach data provision skills (how to complete a three day diet record).
Diabetes Canada and Dietitian's Canada resources on glycemic index will also be reviewed: the Glycemic Index Food Guide, Flip Cards, and Recipes.
|
Educational materials layering Glycemic Index education onto Canada's Food Guide and Diabetes Canada recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Transfer/KM Level 3: Change in average dietary GI
Time Frame: From baseline to 4-6 weeks postpartum
|
Average dietary GI; diet record at baseline, 4-6 weeks post-intervention, 4-6 weeks postpartum
|
From baseline to 4-6 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction/ KM Level 1: Reaction
Time Frame: From baseline to 4-6 weeks postpartum
|
Mixed form Questionnaire (GIQ): Close ended format with True or False, Multiple Choice, and Likert Scale choices.
Open-ended questions for feedback.
|
From baseline to 4-6 weeks postpartum
|
Knowledge/KM Level 2: Learning
Time Frame: From baseline to 4-6 weeks postpartum
|
Average Quiz Score: Close-ended format, Scored by correct answers.
|
From baseline to 4-6 weeks postpartum
|
Acceptability and Applicability of Education/KM Level 3: Transfer (Behaviour Change)
Time Frame: From 4-6 weeks post-intervention to 4-6 weeks post-partum
|
Mixed form Questionnaire (GIQ): Close ended format using Likert Scale and True or False choices.
Open-ended questions for feedback.
|
From 4-6 weeks post-intervention to 4-6 weeks post-partum
|
Results/KM Level 4: Glycemic Control (rate of Self-monitored blood glucose levels within range)
Time Frame: From Baseline to 4-6 weeks post-partum
|
Medical Record (standard care 2-4 time-points per day)
|
From Baseline to 4-6 weeks post-partum
|
Maternal Demographics (eg. age, ethnicity, language spoken, education level and work status)
Time Frame: Baseline
|
Mixed-form Questionnaire (GIQ) and Medical Chart
|
Baseline
|
Maternal Height
Time Frame: Baseline
|
Medical Record, measured in cm.
|
Baseline
|
Maternal Pre-Pregnancy body weight
Time Frame: Baseline
|
Medical Record, measured in kg.
|
Baseline
|
Maternal Weight, during pregnancy
Time Frame: From Baseline to 4-6 weeks post-partum.
|
Medical Record, measured in kg.
|
From Baseline to 4-6 weeks post-partum.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Shannan Grant, PhD, PDt, IWK Health Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Diabetes Canada Clinical Practice Guidelines Expert Committee; Feig DS, Berger H, Donovan L, Godbout A, Kader T, Keely E, Sanghera R. Diabetes and Pregnancy. Can J Diabetes. 2018 Apr;42 Suppl 1:S255-S282. doi: 10.1016/j.jcjd.2017.10.038. No abstract available. Erratum In: Can J Diabetes. 2018 Jun;42(3):337.
- Draffin CR, Alderdice FA, McCance DR, Maresh M, Harper Md Consultant Physician R, McSorley O, Holmes VA. Exploring the needs, concerns and knowledge of women diagnosed with gestational diabetes: A qualitative study. Midwifery. 2016 Sep;40:141-7. doi: 10.1016/j.midw.2016.06.019. Epub 2016 Jun 29.
- Layes, A. The Burden of Diabetes in Atlantic Canada. Public Health Agency of Canada, Atlantic Regional Office; 2011.
- Grant SM, Wolever TMS. Perceived barriers to application of glycaemic index: valid concerns or lost in translation? Nutrients. 2011 Mar;3(3):330-340. doi: 10.3390/nu3030330. Epub 2011 Feb 28.
- Johnston S, Coyer FM, Nash R. Kirkpatrick's Evaluation of Simulation and Debriefing in Health Care Education: A Systematic Review. J Nurs Educ. 2018 Jul 1;57(7):393-398. doi: 10.3928/01484834-20180618-03.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 24, 2019
Primary Completion (ANTICIPATED)
May 31, 2022
Study Completion (ANTICIPATED)
August 30, 2022
Study Registration Dates
First Submitted
October 20, 2019
First Submitted That Met QC Criteria
February 14, 2020
First Posted (ACTUAL)
February 17, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 31, 2022
Last Update Submitted That Met QC Criteria
March 29, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GI in GDM Online
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes Mellitus
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingGestational Diabetes Mellitus in PregnancyFrance
-
i-Health, Inc.CompletedGestational Diabetes Mellitus in PregnancyGermany
-
The Danish Center for Strategic Research on Type...Odense University HospitalCompletedGestational Diabetes Mellitus in PregnancyDenmark
-
Services Institute of Medical Sciences, PakistanCompletedGestational Diabetes Mellitus in PregnancyPakistan
-
Danone Asia Pacific Holdings Pte, Ltd.Nutricia ResearchTerminatedGestational Diabetes Mellitus in PregnancySingapore
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Federal State Budgetary Institution, V. A. Almazov...RecruitingGestational Diabetes Mellitus (GDM)Russian Federation
Clinical Trials on Low Glycemic Index Education
-
Federico II UniversityUnknown
-
University of California, DavisCompleted
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Completed
-
University of TorontoActive, not recruiting
-
Swansea UniversityCompletedCognitive Function | Mood | Glucose Metabolism | Sleep ArchitectureUnited Kingdom
-
Universidad Autonoma de Baja CaliforniaTerminated
-
Shenzhen Institute of Advanced Technology, Chinese...RecruitingHealthy | Food Preferences | HungerChina
-
Brigham and Women's HospitalEpilepsy FoundationNot yet recruiting
-
Chinese University of Hong KongUnknown
-
Göteborg UniversityCompletedDiabetes Mellitus, Type 1